Drug-eluting stents

Antiplatelet

Ultrathin vs Thin-Strut Stents in PCI Patients at High Bleeding Risk

Several in vivo studies have shown that ultrathin stents present lower thrombogenic risk vs. thin-strut stents, which...

Dr. Andrés Rodríguez - 10 October, 2024

Coronary disease

SCAAR Registry: Coronary Angioplasty in Venous Grafts

Most patients undergoing coronary artery bypass graft (CABG) benefit from at least one saphenous vein graft (SVG)....

Dr. Carlos Fava - 2 October, 2024

Chronic Coronary Syndromes

Intramural Hematoma and “Cuttering” as a Rescue Technique

Coronary dissections can be self-limiting or they can progress, generating an intramural hematoma (IMH). The false lumen...

Dr. Omar Tupayachi - 2 October, 2024

Chronic Coronary Syndromes

Long Term Outcomes of RIBS VI, a Study on Bioresorbable Stents in Patients with In-Stent Restenosis

The use of drug eluting stents (DES) is currently recommended for the percutaneous treatment of coronary artery...

Dr. Andrés Rodríguez - 1 October, 2024

Chronic Coronary Syndromes

ESC 2024 | REC-CAGEREE I Trial: Drug Coated Balloon with Bailout Stenting vs. Intended DES for de Novo Lesion Treatment

DES stenting is currently the standard treatment. The development of balloon technology and the coating drugs have...

Dr. Omar Tupayachi - 11 September, 2024

Bifurcations

Stent Optimal Minimal Area and Stent Underexpansion Impact in 2-Stent Left Main Treatment

The upfront 2-stent strategy for left main bifurcation treatment presents a technical challenge and has been associated...

Dr. Andrés Rodríguez - 2 August, 2024

Chronic Ischemic cardiopathy

ULTIMATE III: Use of IVUS for Coronary De Novo Lesion Drug Coated Balloon Angioplasty

Percutaneous coronary intervention (PCI) with drug eluting stents (DES) can present limitations, especially in the form of...

solaci - 12 July, 2024

Coronary disease

Biolimus vs Paclitaxel Coated Balloons for the Treatment of In-Stent Restenosis

Drug eluting stent (DES) in-stent restenosis (ISR) is currently a challenging, seeing as it often requires repeat...

solaci - 2 July, 2024

Ultrathin vs Thin-Strut Stents in PCI Patients at High Bleeding Risk

SCAAR Registry: Coronary Angioplasty in Venous Grafts

Intramural Hematoma and “Cuttering” as a Rescue Technique

Long Term Outcomes of RIBS VI, a Study on Bioresorbable Stents in Patients with In-Stent Restenosis

ESC 2024 | REC-CAGEREE I Trial: Drug Coated Balloon with Bailout Stenting vs. Intended DES for de Novo Lesion Treatment

Stent Optimal Minimal Area and Stent Underexpansion Impact in 2-Stent Left Main Treatment

ULTIMATE III: Use of IVUS for Coronary De Novo Lesion Drug Coated Balloon Angioplasty

Biolimus vs Paclitaxel Coated Balloons for the Treatment of In-Stent Restenosis

Últimas Noticias

Percutaneous Treatment of Atrial Functional Mitral Regurgitation

ACURATE Neo2 Underexpansion: Prevalence and Clinical Implications

Spontaneous Left Main Dissection: Clinical Characteristics, management and Outcomes

Noticias Institucionales

See the best images from the Uruguay 2025 Sessions

How to apply for the SOLACI Research 2025 Grant? Step-by-step explanation video

April 9 – How to Apply for the SOLACI Research Grant 2025? Virtual Zoom Event

Accesos